Brian R. Holloway

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2006 · 702 citations · Full text

Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α

Yi‐Ping Li, Robert J. Schwartz, Ian D. Waddell et al. · The FASEB Journal · 1998 · 481 citations

Muscle Function, Skeletal Muscle Myocytes, Immune Regulation +22

Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

Hideharu Kimura, Kazuo Kasahara, Makoto Kawaishi et al. · Clinical Cancer Research · 2006 · 324 citations · Full text

Non–small-cell Lung Cancer, Serum Dna, Molecular Diagnostic Techniques +14

Skeletal muscle myocytes undergo protein loss and reactive oxygen‐mediated NF‐κB activation in response to tumor necrosis factorα

Yiping Li, Robert J. Schwartz, Ian D. Waddell et al. · The FASEB Journal · 1998 · 153 citations

Altered Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Obese (<i>fa/fa</i>) Zucker Rats: Possible Relationship to Obesity and Neuroendocrine Disturbances

Pauline E. McKibbin, Stephen J. Cotton, S. McMillan et al. · Diabetes · 1991 · 116 citations

Zucker Rats, Neuroendocrinology, Food Restriction +21